Primary biliary cirrhosis and autoantibodies

Japanese Journal of Clinical Immunology

Volumn 31, Issue 1, 2008, Pages 47-55

  Miyachi, K ^a   Miyakawa, H ^b   Oda, M ^c   Horigome, T ^d   Fritzler, Mj ^e  

^a Keigu Clinic   (Japan)

^b Miyakawa Clinic   (Japan)

^c Sannou Hospital   (Japan)

^d NIIGATA UNIVERSITY   (Japan)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anti gp210 antibody; Anti multiple nuclear dot antibody; Anticentromere antibody; Antimitochondrial antibody (AMA); Primary biliary cirrhosis (PBC)

Indexed keywords

AUTOANTIBODY;

BILIARY CIRRHOSIS; BLOOD; CENTROMERE; HUMAN; IMMUNOLOGY; MITOCHONDRION; REVIEW;

AUTOANTIBODIES; CENTROMERE; HUMANS; LIVER CIRRHOSIS, BILIARY; MITOCHONDRIA;

EID: 42449091635     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.31.47     Document Type: Article

References (49)

1. Scheuer P. J.,: Primary biliary cirrhosis. Proc. R. Soc. Med. 60: 1257–1260, 1967.
2. Kaplan M. M.,: Primary biliary cirrhosis. N. Engl. J. Med. 316: 521–528, 1987.
3. Triger D. R., et al.: Epidemiology of primary biliary cirrhosis. Liver 4: 195–200, 1984.
4. Prince M., et al.: Survival and symptom progression in a geographically based cirrhosis: of patients with primary biliary cirrhosis: Follow-up for up to 28 years. Gastroenterology 123: 1044–1051, 2002.
5. Manns M. P., et al.: HLADRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Gastroenterology 101: 1367–1373, 1991.
6. Onishi S., et al.: DNA typing of HLA class IIgene; DRB1*0803 increases the susceptibility to primary bilairy cirrhosis in Japanese. J. Hepatolo 21: 1053–1060, 1994.
7. Berg P. A., et al.: Mitochondrial antibodies in primary biliary cirrhosis. Localization of the antigen to mitochondrial membranes. J. Exp. Med. 126: 277–290, 1967.
8. Berg P. A., et al.: Antimitochondrial antibodies in primary biliary cirrhosis. J. Hepatolo. 2: 123–131, 1986.
9. Makinen D., et al.: Anticentromere antibodies in primary biliary cirrhosis. Arthritis Rheum 26: 914–917, 1983.
10. McHugh N. J., et al.: Autoantibodies to mitochondrial and centromere antigens in primary biliary cirrhosis and systemic sclerosis. Clin. Exp. Immunol. 812: 244–249, 1990.
11. Ruffatti A., et al.: Nuclear membrane-staining anti-nuclear antibody in patients with primary biliary cirrhosis. J. Clin. Immunolo. 5: 357–361, 1985.
12. Lazano F., et al.: Autoantibodies against nuclear envelope-associated proteins against primary biliary cirrhosis. Hepatology 8: 930–938, 1988.
13. Lassoued K., et al.: Autoantibodies 200kD polypeptides of the nuclear envelope: a new serologic marker of primary biliary cirrhosis. Clin. Exp. Immunol. 74: 283–288, 1988.
14. Nickowitz R. E., et al.: Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis. Gastroenterology 106: 193–199, 1994.
15. Miyachi K., et al.: Precipitating antibodies to mitochondrial antigens in patients with primary biliary cirrhosis. Clin. Exp. Immunol. 39: 599–606, 1980.
16. Miyachi K., et al.: Precipitating antimitochondrial antibodies in Japanese patients with primary biliary cirrhosis. Amer. J. Gastroenterol. 79: 704–709, 1984.
17. Fritzler M. J., et al.: The use and abuse of commercial kits used to detect autoantibodies. Arthritis Res. Ther. 5: 192–201, 2003.
18. Abe K., et al.: Anti-liver/kidney microsome 1 positive chronic hepatitis C with type 1 cryoglobulinemia responding to interferon. Intern. Med. 34: 1114–1119, 1995.
19. Yamamoto A. M., et al.: Study of CYP2D6 gene in children with autoimmune hepatitis and p4502D6 autoantibodies. Clin. Exp. Immunol. 87: 251–255, 1992.
20. Gershwin M. E., et al.: Identification and specificity of a cDNA encoding the 70kd mitochondrial antigen recognized in primary biliary cirrhosis. J. Immunol. 138: 3525–3531, 1987.
21. Bassendine M. F., et al.: Identification and characterization of four mitochondrial autoantigen in primary biliary cirrhosis. Semin. Liver Dis. 9: 124–131, 1989.
22. Fritzler M. J., Fritzler M. L.,: The emergence of multiplexed technologies as diagnostic platforms in systemic autoimmune diseases. Current Medicinal Chemistry. 13: 2503–2512, 2006.
23. Enarson P., et al.: Autoantigens of the nuclear pore complex J. Mol. Med. 82: 423–33, 2004.
24. Itoh S., et al.: Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. J. Gastroenterol. Hepatol. 13: 257–265, 1998.
25. Nakamura M., et al.: anti-gp210 and anticentromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 45: 118–127, 2007.
26. Miyachi K., et al.: A male patient who developed late-onset primary biliary cirrhosis presenting with antinuclear envelope antibody. Modern Rheumatol. 12: 246–249, 2002.
27. Szostecki C. et al.: Autoantibodies against nuclear dots in primary biliary cirrhosis. Seminars in liver disease 17: 71–78, 1997.
28. Miyachi K., et al.: Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study. J. Autoimmunity 20: 247–254, 2003.
29. Konstantinov K., et al.: Integral membrane proteins associated with the nuclear lamina are novel autoimmune antigens of the nuclear envelope. Clin Immunol Immunopathol. 74: 89~99, 1995.
30. Miyachi K., et al.: Primary biliary cirrhosis sera recognize not only gp210 but also proteins of the p62complex bearing N-acetyl glucose a-mine residues from rat liver nuclear envelope. Mol. Biol. Rep. 23: 227–234, 1996.
31. Ou Y., et al.: The nuclear pore complex protein Tpr is a common autoantigen in sera that demonstrate nuclear envelope staining by indirect immunofluorescence. Clin. Exp. Immunol. 136: 379–387, 2004.
32. Miyachi K., et al.: A novel antibody directed against a three dimensional configuration of a 95-kDa protein in patients with autoimmune hepatic disease. Scand. J. Immunol. 47: 63–68, 1998.
33. Woodman P. G.,: a protein coping with multiple identities. J Cell Science 116: 4283–4290, 2003.
34. Peters J., et al.: An abundant and ubiquitous homooligomeric ring-shaped ATPase particle related to the putative vesicle fusion proteins Sec18p and NSF. EMBO J. 9: 1757–1767, 1990.
35. Miyachi K., et al.: Autoantibodies from primary biliary cirrhosis patients with anti-p95c antibodies bind to recombinant p97/VCP and inhibit in vitro nuclear envelope assembly. Clin. Exp. Immunol. 136: 562–573, 2004.
36. Miyachi K., et al.: Anti-p97/VCP antibody markers for a subset of primary biliary cirrhosis patients with milder disease? Scand. J. Immunol. 63: 376–382, 2006.
37. Sobajima J., et al.: Novel autoantigen of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: nonhistone chromosomal proteins, HMG1and HMG2. Clin. Exp. Immunol. 107:135–140, 1997.
38. Sobajima J., et al.: High mobility group (HMG) non histone chromosomal protein HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophile cytoplasmioc antibodies in autoimmune hepatitis. Gut 44:867–873,1999.
39. Miyachi K., et al.: Inositol 1,4,5- trisphos-phate receptors are autoantibody target antigens in patients with Sjogren's syndrome and other systemic rheumatic diseases. Modern Rheumatol. 17: 137–143, 2007.
40. Miyachi K., et al.: A case of limited cutaneous systemic sclerosis developing anti-mitochondri-al antibody positive primary biliary cirrhosis after acute myocardial infarction. Clin. Rheumatol. 26: 1571–1574, 2007.
41. Fukushima N., et al.: Establishment and structural analysis of human monoclonal antibody to E2 component of 2 oxoglutarate dehydorogenase complex generated from a patient with primary biliary cirrhosis. Int. Immunol. 7: 1047–1055.1995.
42. Coppel R. L., et al.: Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: Dihydrolipoamide acetyltransferase. Proc. Natl. Acad. Sci. USA 85:7317–7321,1988.
43. Matsui M., et al.: Human monoclonal antibodies from a patient with primary biliary cirrhosis which recognize two distinct autoepitopes in the E2 component of the pyruvate de-hydogenase complex. Hepatology 18: 1069–1077, 1993.
44. Nickowitz R. E., Worman H. J.,: Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within cytoplasmictail of nuclear pore membrane glycoprotein Gp210. J. Exp. Med. 178: 2237–2242, 1993.
45. Wesierska-Gadek J., et al.: Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-termainal domain of nuclear complex glycoprotein gp210. J Exp. Med. 182: 159–162, 1995.
46. Wesierska-Gadek J., et al.: Anti-gp210 antibodies in sera of patients with primary biliary cirrhosis. Identification of a 64-kDa fragment of gp210 as a major epitope. Human Antibody Hibrodomas. 7:167–174, 1996.
47. Tartakovsky F., Worman H. J.,: Detection of Gp210 auto antibodies in primary biliary cirrhosis using a recombinant protein containing the predominant autoepitope. Hepatology 21: 495–500, 1995.
48. Bandin O., et al.: Specificity and sensitivity of gp210 auto antibodies detected using an enzyme- linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis. Hepatology 23: 1020–1024, 1996.
49. Shibata M., et al.: Detection of anti-gp210 antibodies in primary biliary cirrhosis by enzyme-linked immunosorbent assay with a synthesized polypeptide. Yamanaka M., Toda G., Tanaka T., eds. Progress in Hepatology, volume 5, Liver and Immunonology Elsevier Science B.V. pp 125–133, 1999.